文献速递衰弱、肌少症与跌倒老年综合评估

团体与个体生活方式整合功能锻炼(LiFE)项目的跌倒及成本效果比较:LiFE-is-LiFE非劣效试验最终结果

Comparison of falls and cost-effectiveness of the group versus individually delivered Lifestyle-integrated Functional Exercise (LiFE) program: final results from the LiFE-is-LiFE non-inferiority trial.
PubMed 文献 · Age Ageing · 2023-01-01

这项单盲、随机、多中心非劣效试验在社区70岁以上有跌倒风险或跌倒史的309名老年人中比较团体交付(gLiFE)与个体居家交付(LiFE)项目。12个月随访时,体力活动调整后跌倒风险的非劣效性结论不确定(IRR 0.96;95%CI 0.67-1.37);gLiFE干预成本较低但成本效果不确定;gLiFE组体力活动增加更明显(+1,090步/天;95%CI -31-1,168);两种形式跌倒次数和跌倒人数均减少。

要点

  • gLiFE与LiFE在12个月体力活动调整后跌倒风险上的非劣效性结论不确定。
  • gLiFE干预成本低于LiFE,但成本效果不确定,并非明确更优。
  • gLiFE组体力活动增加约1,090步/天,LiFE组增加约569步/天,两组跌倒均减少。

核心结论

  • 12个月随访时,团体交付gLiFE相比个体交付LiFE在体力活动调整后跌倒风险方面的非劣效性结论不确定。
  • gLiFE干预成本较低,但成本效果不确定,不能明确判定gLiFE更具成本效果优势。
  • 两种形式均使跌倒次数和跌倒人数减少,体力活动增加在两组均有临床相关性,gLiFE组增幅接近LiFE组的两倍。

研究设计与样本

  • 单盲、随机、多中心非劣效试验,设置于社区。
  • 共纳入309名70岁及以上有跌倒风险或跌倒史的成人,gLiFE组n=153,LiFE组n=156。
  • LiFE由干预者在参与者家中一对一交付,gLiFE以团体形式交付。
  • 采用负二项回归比较体力活动调整后跌倒风险的发病率比(IRR)。
  • 成本效果以增量成本效果比和成本效果可接受曲线呈现,效果指标包括质量调整生命年、体力活动和跌倒。

主要发现

  • 体力活动调整后跌倒风险的非劣效性结论不确定(IRR 0.96;95%置信区间0.67-1.37)。
  • gLiFE干预成本低于LiFE,但成本效果不确定。
  • 两种形式的跌倒次数和跌倒人数均减少。

关键数值与推荐

  • 非劣效性主要结局为12个月体力活动调整后跌倒风险,IRR 0.96(95%CI 0.67-1.37)。
  • 成本效果分析考虑质量调整生命年、体力活动和跌倒作为效果指标,gLiFE成本较低但成本效果不确定。

临床怎么用

  • 团体交付gLiFE可降低干预成本,但现有证据不足以确认其在跌倒风险上非劣于个体交付LiFE。
  • 两种形式均可能减少跌倒并增加体力活动,gLiFE在提升体力活动方面幅度更大。
  • 临床选择交付形式时需结合资源条件与个体化需求,并告知成本效果尚不确定。

局限性

  • 非劣效性结论不确定,不能排除gLiFE在跌倒风险上劣于LiFE的可能。
  • 成本效果结果不确定,无法明确推荐更具成本效果的交付形式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: the individually delivered Lifestyle-integrated Functional Exercise (LiFE) was shown to improve physical activity (PA) and reduce fall incidence, however being rather resource-consuming due to one-to-one delivery. A potentially less resource-intensive group format (gLiFE) was developed and compared against the original program, considering higher risk of falling due to possible PA enhancement. OBJECTIVE: to investigate non-inferiority in terms of PA-adjusted fall risk and cost-effectiveness of gLiFE at 12-month follow-up. DESIGN: single-blinded, randomised, multi-centre non-inferiority trial. SETTING: community. SUBJECTS: in total, 309 adults aged 70+ years at risk of or with history of falling; n = 153 in gLiFE, n = 156 in LiFE. METHODS: LiFE was delivered one-to-one at the participants' homes, gLiFE in a group. PA-adjusted fall risk was analysed using negative binomial regression to compare incidence rate ratios (IRR). Cost-effectiveness was presented by incremental cost-effectiveness ratios and cost-effectiveness acceptability curves, considering quality-adjusted life years, PA and falls as effect measures. Secondary analyses included PA (steps/day) and fall outcomes. RESULTS: non-inferiority was inconclusive (IRR 0.96; 95% confidence interval, CI 0.67; 1.37); intervention costs were lower for gLiFE, but cost-effectiveness was uncertain. gLiFE participants significantly increased PA (+1,090 steps/day; 95% CI 345 and 1.835) versus insignificant increase in LiFE (+569, 95% CI -31; 1,168). Number of falls and fallers were reduced in both formats. CONCLUSION: non-inferiority of gLiFE compared with LiFE was inconclusive after 12 months. Increases in PA were clinically relevant in both groups, although nearly twice as high in gLiFE. Despite lower intervention costs of gLiFE, it was not clearly superior in terms of cost-effectiveness.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Jansen CP, Gottschalk S, Nerz C, et al. Comparison of falls and cost-effectiveness of the group versus individually delivered Lifestyle-integrated Functional Exercise (LiFE) program: final results from the LiFE-is-LiFE non-inferiority trial. Age Ageing. 2023. PMID: 36702515. doi:10.1093/ageing/afac331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。